Oral delivery of alloantigen combined with non-depleting anti-CD4 monoclonal antibody induces indefinite survival of cardiac allografts and generates CD4 + regulatory T cells

Saved in:
Bibliographic Details
Published inTransplantation proceedings Vol. 32; no. 7; p. 2035
Main Authors Niimi, M, Ikeda, Y, Shirasugi, N, Shatari, T, Takami, H, Kodaira, S, Matsumoto, K, Hamano, K, Esato, K, Hara, M, Wood, K.J
Format Journal Article Conference Proceeding
LanguageEnglish
Published New York, NY Elsevier Inc 01.11.2000
Elsevier Science
Subjects
Administration, Oral
Adoptive Transfer
Animals
Antibodies, Monoclonal - pharmacology
Biological and medical sciences
CD4 Antigens - immunology
CD4-Positive T-Lymphocytes - immunology
CD8-Positive T-Lymphocytes - immunology
Graft Survival - immunology
Heart Transplantation - immunology
Heart Transplantation - physiology
Immunosuppression - methods
Isoantigens - administration & dosage
Isoantigens - immunology
Lymphocyte Transfusion
Medical sciences
Mice
Mice, Inbred C57BL
Mice, Inbred CBA
Mice, Transgenic
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Surgery of the heart
Transplantation, Homologous
Heart
Prognosis
Thymus gland
Rodentia
Oral administration
Helper cell
Monoclonal antibody
Homotransplantation
Cell subpopulation
Survival
Vertebrata
Mammalia
Alloantigen
Treatment
Mouse
Animal
T-Lymphocyte
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0041-1345
1873-2623
DOI:10.1016/S0041-1345(00)01546-3